Methodist Health System Services
Jennie Edmundson Cancer Center Cancer Registry
933 E. Pierce St.
Council Bluffs, IA 51503
Established in 1994, the Cancer Registry began with the collaboration of physicians and administrative staff who recognized the need for the most current and complete information on each cancer patient diagnosed or treated at Jennie Edmundson Hospital.
Every cancer patient matters at Jennie Edmundson Hospital and is followed for a lifetime to ensure the best possible outcome.
Methodist Hospital Tumor Registry
Howard B. Hunt Tumor Registry
8601 W. Dodge Road, Suite 246
Omaha, NE 68114
In 1927, a young Nebraska physician named Howard B. Hunt entered the field of radiology. In that same year, cancer claimed the lives of 95,000 Americans. Dr. Hunt came to realize the key to the battle against cancer was understanding not only collective statistics, but also the breadth and scope of each individual cancer patient's journey. To begin collecting that information in a meaningful format, Dr. Hunt established the state's first tumor registry at Methodist Hospital. The registry was later named in his honor.
The Howard B. Hunt Tumor Registry has been tracking treatment outcomes since then. With a 96 percent follow-up rate, these cancer treatment outcomes are tracked to measure the quality of our care against both national and local trends.
Accredited by Commission on Cancer (CoC)
Approval by the Commission on Cancer is granted only to those facilities that have voluntarily committed to provide the best in cancer diagnosis and treatment and are able to comply with established Commission on Cancer standards. Methodist Hospital Tumor Registry received an approval with commendation in 2004.
Being a CoC-approved cancer program demonstrates a facility’s ongoing commitment to providing high-quality, multidisciplinary cancer care. The Commission wishes to acknowledge the hard work and dedication these programs put forth in meeting CoC standards and improving the reliability of cancer data, enabling the best possible outcomes for today’s cancer patients.